<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
<channel rdf:about="http://hdl.handle.net/10468/386">
<title>College of Medicine and Health - Theses</title>
<link>http://hdl.handle.net/10468/386</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://hdl.handle.net/10468/1092"/>
<rdf:li rdf:resource="http://hdl.handle.net/10468/911"/>
<rdf:li rdf:resource="http://hdl.handle.net/10468/582"/>
<rdf:li rdf:resource="http://hdl.handle.net/10468/573"/>
</rdf:Seq>
</items>
<dc:date>2013-05-25T22:06:54Z</dc:date>
</channel>
<item rdf:about="http://hdl.handle.net/10468/1092">
<title>Ryanodine receptor expression in trophoblasts</title>
<link>http://hdl.handle.net/10468/1092</link>
<description>Ryanodine receptor expression in trophoblasts
Zheng, Limian
Trophoblasts of the placenta are the frontline cells involved in communication&#13;
and exchange of materials between the mother and fetus. Within trophoblasts, calcium&#13;
signalling proteins are richly expressed. Intracellular free calcium ions are a key&#13;
second messenger, regulating various cellular activities. Transcellular Ca2+ transport&#13;
through trophoblasts is essential in fetal skeleton formation. Ryanodine receptors&#13;
(RyRs) are high conductance cation channels that mediate Ca2+ release from&#13;
intracellular stores to the cytoplasm. To date, the roles of RyRs in trophoblasts have&#13;
not been reported. By use of reverse transcription PCR and western blotting, the&#13;
current study revealed that RyRs are expressed in model trophoblast cell lines (BeWo&#13;
and JEG-3) and in human first trimester and term placental villi.&#13;
Immunohistochemistry of human placental sections indicated that both&#13;
syncytiotrophoblast and cytotrophoblast cell layers were positively stained by&#13;
antibodies recognising RyRs; likewise, expression of RyR isoforms was also revealed&#13;
in BeWo and JEG-3 cells by immunofluorescence microscopy. In addition, changes in&#13;
[Ca2+]i were observed in both BeWo and JEG-3 cells upon application of various RyR&#13;
agonists and antagonists, using fura-2 fluorescent videomicroscopy. Furthermore,&#13;
endogenous placental peptide hormones, namely angiotensin II, arginine vasopressin&#13;
and endothelin 1, were demonstrated to increase [Ca2+]i in BeWo cells, and such&#13;
increases were suppressed by RyR antagonists and by blockers of the corresponding&#13;
peptide hormone receptors. These findings indicate that 1) multiple RyR subtypes are&#13;
expressed in human trophoblasts; 2) functional RyRs in BeWo and JEG-3 cells&#13;
response to both RyR agonists and antagonists; 3) RyRs in BeWo cells mediate Ca2+&#13;
release from intracellular store in response to the indirect stimulation by endogenous&#13;
peptides. These observations suggest that RyR contributes to trophoblastic cellular&#13;
Ca2+ homeostasis; trophoblastic RyRs are also involved in the functional regulation of&#13;
human placenta by coupling to endogenous placental peptide-induced signalling&#13;
pathways.
</description>
<dc:date>2013-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://hdl.handle.net/10468/911">
<title>Vulnerability or resilience? Psycho-social factors associated with deliberate self-harm among adolescents</title>
<link>http://hdl.handle.net/10468/911</link>
<description>Vulnerability or resilience? Psycho-social factors associated with deliberate self-harm among adolescents
McMahon, Elaine M.
Background: Deliberate self-harm (DSH) is common among adolescents in Ireland and internationally.&#13;
Psychological factors, negative life events and lifestyle factors have been found to be associated&#13;
with self-harm in this group. However, large scale population-based studies of adolescent selfharm&#13;
and its correlates have been lacking, and internationally a standardised methodology was&#13;
needed to facilitate comparative studies. The focus on vulnerability which has been prevalent in&#13;
this field has meant that research has failed to examine resilient adaptation among at-risk&#13;
adolescents.&#13;
Method: Data were obtained from a cross-sectional school-based study conducted in Ireland and in each&#13;
of the six other centres which participated in the Child and Adolescent Self-harm in Europe&#13;
(CASE) study. In Ireland, 3,881 adolescents in 39 schools in completing the anonymous&#13;
questionnaire, while across all 7 centres, over 30,000 young people participated. Data were&#13;
gathered on health and lifestyle, self-harm thoughts and behaviour, a wide range of life events,&#13;
psychological characteristics (anxiety and depressive symptoms, self-esteem, impulsivity and&#13;
coping style), and support available to young people.&#13;
Results: This thesis reports the findings of the Irish CASE centre as well as one international study. The&#13;
factors associated with DSH among Irish adolescents differed by gender, but among both&#13;
genders drug use and knowing a friend who had engaged in self-harm were associated with DSH.&#13;
Among Irish boys, strong associations were found between bullying and poor mental health and&#13;
DSH. Among boys who had been bullied, psychological and school factors were associated&#13;
with DSH, while family support was protective.&#13;
Links between stressful life events, psychological characteristics and DSH within the&#13;
international CASE sample were examined. Increased history of self-harm thoughts and acts&#13;
was associated with greater depression, anxiety and impulsivity, lower self esteem and an&#13;
increased prevalence of ten different negative life events, supporting the hypothesis of a “dose-response”&#13;
relationship between these risk factors and the self-harm process.&#13;
Associations between coping style, mental health factors (depressive symptoms, anxiety and&#13;
self-esteem) and self-harm were examined among Irish adolescents. Emotion-oriented coping&#13;
was strongly associated with poorer mental health and self-harm thoughts and acts. A mediating&#13;
effect of emotion-oriented coping on associations between mental health factors and DSH was&#13;
found for both genders and between problem-oriented coping and mental health factors for&#13;
girls. Similar mediating effects of coping style were found when risk of self-harm thoughts was&#13;
examined.&#13;
Resilient adaptation among adolescents exposed to suicidal behaviour of others was examined.&#13;
Self-harm thoughts were common in these adolescents. Among those exposed to suicidal&#13;
behaviour of others, vulnerability factors were drug use and higher levels of anxiety among&#13;
boys, while for girls drug use, bullying and abuse were vulnerability factors, while resilience&#13;
was associated with higher self-esteem and use of problem-oriented coping.&#13;
Conclusion: These findings can aid in the identification of young people at risk of self-harm in the school&#13;
setting and highlight the importance of mental health, peer-related and lifestyle factors in the&#13;
development of DSH. High-risk groups of young people such as bullying victims and those&#13;
exposed to suicidal behaviour of others have distinctive profiles of risk factors which differ&#13;
from those of their peers. Findings relating to the importance of positive coping skills can&#13;
inform positive mental health programmes, many of which aim to enhance life skills and build resilience among young people. Knowledge of the factors associated with positive adaptation&#13;
among at-risk adolescents can inform prevention efforts among this group.
</description>
<dc:date>2012-08-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://hdl.handle.net/10468/582">
<title>The meaning of environmental control systems (ECS) for people with spinal cord injury: An occupational therapist explores an intervention</title>
<link>http://hdl.handle.net/10468/582</link>
<description>The meaning of environmental control systems (ECS) for people with spinal cord injury: An occupational therapist explores an intervention
Verdonck, Michèle Claire
Environmental Control Systems (ECS), enable people with high cervical Spinal Cord Injury (high SCI) to control and access everyday electronic devices. In Ireland, however, access for those who might benefit from ECS is limited. This study used a qualitative approach to explore the insider experience of an ECS starter-pack developed by the author, an occupational therapist. The primary research questions: what is it really like to live with ECS, and what does it mean to live with ECS, were explored using a phenomenological methodology conducted in three phases.&#13;
In Phase 1 fifteen people with high SCI met twice in four focus groups to discuss experiences and expectations of ECS. Thematic analysis (Krueger &amp; Casey, 2000), influenced by the psychological phenomenological approach (Creswell, 1998), yielded three categories of rich, practical, phenomenological findings: ECS Usage and utility; ECS Expectations and The meaning of living with ECS.&#13;
Phase 1 findings informed Phase 2 which consisted of the development of a generic electronic assistive technology pack (GrEAT) that included commercially available constituents as well as short instructional videos and an information booklet. This second phase culminated in a one-person, three-week pilot trial.&#13;
Phase 3 involved a six person, 8-week trial of the GrEAT, followed by individual in-depth interviews. Interpretative Phenomenological Analysis IPA (Smith, Larkin &amp; Flowers, 2009), aided by computer software ATLAS.ti and iMindmap, guided data analysis and identification of themes. Getting used to ECS, experienced as both a hassle and engaging, resulted in participants being able to Take back a little of what you have lost, which involved both feeling enabled and reclaiming a little doing.&#13;
The findings of this study provide substantial insights into what it is like to live with ECS and the meanings attributed to that experience. Several practical, real world implications are discussed.
</description>
<dc:date>2012-05-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://hdl.handle.net/10468/573">
<title>Paracetamol metabolism in postoperative patients</title>
<link>http://hdl.handle.net/10468/573</link>
<description>Paracetamol metabolism in postoperative patients
Murphy, Philip Gerard MacHale
Introduction: &#13;
Despite being available for more than 50 years, there is still much to learn about paracetamol. Postoperative analgesic regimens that maintain good pain control while minimising exposure to opiates are beneficial and paracetamol has had a resurgence in this role since an IV formulation came to market. However there is evidence to suggest currently licensed doses are sub-therapeutic, especially when administered orally or rectally. Higher, unlicensed doses are now being advocated but, prior to this study, there was little evidence of their safety in surgical patients. When assessing drug safety in surgical patients a number of surgery and patient related factors influence results, and these must be considered.&#13;
Methods: &#13;
Major and intermediate surgical patients were recruited from two hospitals in Ireland. They were administered IV paracetamol at either 9g or 4g daily doses. In addition they received daily sub therapeutic doses of four other medicines to indicate the activity of their CYP450 enzymes that are involved in paracetamol metabolism. Urine and blood samples were collected to determine paracetamol pharmacokinetics, CYP450 activity, inflammatory cytokine concentration and for evidence of hepatotoxicity. &#13;
Results: &#13;
There were 33 patients that participated in the study. There was no evidence of clinically significant hepatotoxicity occurring in any patient during the study period, but there could have been changes following this time. Paracetamol disposition was shown to change, however half-life remained relatively constant. There were a number of changes to the way paracetamol was metabolised following surgery that maintained this rate of elimination.&#13;
Conclusion:&#13;
Doses of up to 9g per day given to major surgical patients for up to five days postoperatively produced no evidence of hepatotoxicity. Further research is warranted to determine the clinical utility of these higher doses
</description>
<dc:date>2012-01-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
